These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3533972)

  • 1. Inhibition of Semliki Forest virus multiplication by ribavirin: a potential method for the monitoring of antiviral agents in serum.
    van Tiel FH; Harmsen M; Kraaijeveld CA; Snippe H
    J Virol Methods; 1986 Sep; 14(2):119-25. PubMed ID: 3533972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid detection of Semliki Forest virus replication in cell culture with peroxidase-labeled monoclonal antibodies: determination of inhibitory concentrations of monoclonal antibodies and ribavirin.
    Van Tiel FH; Harmsen T; Boere WA; Kraaijeveld CA; Snippe H
    Antiviral Res; 1985; Suppl 1():101-6. PubMed ID: 3909957
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of Semliki Forest virus multiplication in L-cells by combinations of interferon and ribavirin as measured by plaque titration and direct enzyme immunoassay.
    Harmsen T; Van Veenendaal D; Kraaijeveld CA
    Zentralbl Bakteriol; 1994 Jan; 280(3):386-91. PubMed ID: 7513217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of inhibitory concentrations of antiviral agents in cell culture by use of an enzyme immunoassay with virus-specific, peroxidase-labeled monoclonal antibodies.
    van Tiel FH; Boere WA; Harmsen T; Kraaijeveld CA; Snippe H
    Antimicrob Agents Chemother; 1985 May; 27(5):802-5. PubMed ID: 3925876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid determination of neutralizing antibodies to Semliki Forest virus in serum by enzyme immunoassay in cell culture with virus-specific monoclonal antibodies.
    van Tiel FH; Harmsen T; Wagenaar M; Boere WA; Kraaijeveld CA; Snippe H
    J Clin Microbiol; 1986 Oct; 24(4):665-8. PubMed ID: 3533979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A neutralization-inhibition enzyme immunoassay for anti-idiotypic antibodies that block monoclonal antibodies neutralizing Semliki Forest virus.
    Oosterlaken TA; Harmsen M; Tangerman C; Schielen P; Kraaijeveld CA; Snippe H
    J Immunol Methods; 1988 Dec; 115(2):255-61. PubMed ID: 3058808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme immunoassay of interferon with peroxidase-labelled virus-specific monoclonal antibodies.
    Van Tiel FH; Boere WA; Harmsen T; Benaissa-Trouw BJ; Kraaijeveld CA; Snippe H
    J Gen Virol; 1985 Jun; 66 ( Pt 6)():1353-6. PubMed ID: 2409224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro inhibition of Chikungunya and Semliki Forest viruses replication by antiviral compounds: synergistic effect of interferon-alpha and ribavirin combination.
    Briolant S; Garin D; Scaramozzino N; Jouan A; Crance JM
    Antiviral Res; 2004 Feb; 61(2):111-7. PubMed ID: 14670584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral activity and mode of action of ribavirin 5'-sulfamate against Semliki Forest virus.
    Smee DF; Alaghamandan HA; Kini GD; Robins RK
    Antiviral Res; 1988 Dec; 10(6):253-62. PubMed ID: 2854956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Semliki Forest virus in cell culture by use of an enzyme immunoassay with peroxidase-labeled monoclonal antibodies specific for glycoproteins E1 and E2.
    van Tiel FH; Boere WA; Vinjé J; Harmsen T; Benaissa-Trouw BJ; Kraaijeveld CA; Snippe H
    J Clin Microbiol; 1984 Sep; 20(3):387-90. PubMed ID: 6386855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In situ enzyme immunoassay for antiviral susceptibility testing of respiratory syncytial virus.
    Kang JO; Pai CH
    Am J Clin Pathol; 1989 Mar; 91(3):323-6. PubMed ID: 2646911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection by a solid phase independent enzyme immunoassay of monoclonal anti-idiotypic antibodies against monoclonal antibodies neutralizing Semliki Forest virus and encephalomyocarditis virus.
    Harmsen M; Oosterlaken TA; Tangerman C; Snippe H; Kraaijeveld CA
    J Virol Methods; 1993 Jul; 43(2):137-46. PubMed ID: 8396153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of remantadine and ribavirin on the production and antiviral action of human interferon types I and II].
    Nosik DN; Aspetov RD; Novokhatskiĭ AS
    Antibiotiki; 1982 Jan; 27(1):49-54. PubMed ID: 6174074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of complement in monoclonal antibody-mediated protection against virulent Semliki Forest virus.
    Boere WA; Benaissa-Trouw BJ; Harmsen T; Erich T; Kraaijeveld CA; Snippe H
    Immunology; 1986 Aug; 58(4):553-9. PubMed ID: 3015781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homologous interference of lymphocytic choriomeningitis virus involves a ribavirin-susceptible block in virus replication.
    Géssner A; Lother H
    J Virol; 1989 Apr; 63(4):1827-32. PubMed ID: 2926867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralizing and non-neutralizing monoclonal antibodies to the E2 glycoprotein of Semliki Forest virus can protect mice from lethal encephalitis.
    Boere WA; Benaissa-Trouw BJ; Harmsen M; Kraaijeveld CA; Snippe H
    J Gen Virol; 1983 Jun; 64 (Pt 6)():1405-8. PubMed ID: 6854274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The genomic sequence of defective interfering Semliki Forest virus (SFV) determines its ability to be replicated in mouse brain and to protect against a lethal SFV infection in vivo.
    Thomson M; White CL; Dimmock NJ
    Virology; 1998 Feb; 241(2):215-23. PubMed ID: 9499796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenic differences between virulent and avirulent strains of Semliki Forest viruses detected with monoclonal antibodies. Brief report.
    Boere WA; Harmsen M; Kraaijeveld CA; Snippe H
    Arch Virol; 1986; 88(1-2):105-12. PubMed ID: 2420309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of distinct antigenic determinants on Semliki Forest virus by using monoclonal antibodies with different antiviral activities.
    Boere WA; Harmsen T; Vinjé J; Benaissa-Trouw BJ; Kraaijeveld CA; Snippe H
    J Virol; 1984 Nov; 52(2):575-82. PubMed ID: 6208379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Following Acute Encephalitis, Semliki Forest Virus is Undetectable in the Brain by Infectivity Assays but Functional Virus RNA Capable of Generating Infectious Virus Persists for Life.
    Fragkoudis R; Dixon-Ballany CM; Zagrajek AK; Kedzierski L; Fazakerley JK
    Viruses; 2018 May; 10(5):. PubMed ID: 29783708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.